Long-term melatonin use (1+ year) for insomnia may increase heart failure risk, hospitalization, and mortality, according to a new study. Experts advise caution and further research is needed on heart effects.
Research indicates cannabis-based medicine improves sleep, mood, and pain in insomnia patients over 18 months, with few side effects. Further trials are needed to confirm efficacy.
Study reveals anxiety symptoms stabilize faster in teen boys than girls. Depressive symptom interactions become fixed in adults, potentially leading to treatment-resistant depression. Early insomnia persists.
